Search...
⌘K

Horowitz Index (PF Ratio)
Horowitz Index (PF Ratio)
Used to assess the severity of hypoxemia in patients

Horowitz Index (PF Ratio)
Horowitz Index (PF Ratio)
Used to assess the severity of hypoxemia in patients
Instructions
The Horowitz Index (PaO₂/FiO₂ ratio or PF ratio) is a bedside tool used to assess the severity of hypoxemia in patients, particularly in acute respiratory distress syndrome (ARDS). To use, measure the arterial partial pressure of oxygen (PaO₂) via arterial blood gas and divide it by the fraction of inspired oxygen (FiO₂) the patient is receiving. The ratio helps clinicians categorize the severity of oxygen impairment, guide ventilatory strategies, and track treatment response. It is especially useful in intensive care and critical care settings.
Overview
When to use
Why use
Evidences
Interpretation
PF Ratio (PaO₂/FiO₂) | Severity Category |
> 300 | Normal / No ARDS |
200 – 300 | Mild ARDS |
100 – 200 | Moderate ARDS |
< 100 | Severe ARDS |
The Horowitz index (P/F ratio) is PaO2 divided by FiO2 and is used to quantify hypoxemia, including staging ARDS in the Berlin definition; thresholds of 300, 200, and 100 mmHg correspond to mild, moderate, and severe ARDS, respectively, and SpO2/FiO2 is an acceptable surrogate when arterial gases are unavailable in many settings.
https://litfl.com/pao2-fio2-ratio/
ARDS severity is categorized by P/F with PEEP ≥5 cm H2O and acute onset with bilateral opacities not fully explained by cardiac failure; P/F 201–300 (mild), 101–200 (moderate), ≤100 (severe)
https://pmc.ncbi.nlm.nih.gov/articles/PMC8075801/
Because P/F depends on ventilator settings, a proposed P/FP metric (PaO2/(FiO2×PEEP)) reclassifies a substantial fraction of patients and may better align severity with support intensity, though it is not yet guideline standard
https://pmc.ncbi.nlm.nih.gov/articles/PMC8350287/
For a given shunt, P/F falls as FiO2 rises; estimating the “best” FiO2 when calculating P/F can reduce variability and improve comparability across patients and time
https://pmc.ncbi.nlm.nih.gov/articles/PMC9374145/
Particularly helpful for triage, resource‑limited settings, and continuous monitoring; accuracy declines at very high SpO2 values due to saturation curve flattening
https://pmc.ncbi.nlm.nih.gov/articles/PMC8664040/
Overview
When to use
Why use
Evidences
The Horowitz Index, also known as the PaO₂/FiO₂ ratio (PF ratio), is a widely applied clinical measure to evaluate oxygen exchange efficiency in patients with acute respiratory failure, most commonly those with acute respiratory distress syndrome (ARDS). It reflects how effectively the lungs transfer oxygen from inhaled air into the bloodstream by comparing arterial oxygen pressure (PaO₂) to the fraction of inspired oxygen (FiO₂). This straightforward calculation provides clinicians with a practical, standardized method to quantify hypoxemia and monitor disease progression.
One of its key strengths lies in its role in ARDS diagnosis and classification. According to the Berlin Definition, ARDS is stratified into mild, moderate, and severe categories based on PF ratio cutoffs, with lower ratios indicating more critical impairment. This grading not only assists in risk stratification but also helps guide therapeutic interventions such as adjusting ventilator settings, deciding on prone positioning, or considering advanced rescue therapies like extracorporeal membrane oxygenation (ECMO).
The PF ratio is advantageous because it adjusts PaO₂ to the FiO₂ level, making it more comparable across patients receiving different oxygen concentrations. However, it should be interpreted in context, as factors like positive end-expiratory pressure (PEEP), altitude, and hemoglobin levels may affect readings. It also does not account for other important gas exchange metrics such as carbon dioxide clearance.
Overview
When to use
Why use
Evidences
Interpretation
PF Ratio (PaO₂/FiO₂) | Severity Category |
> 300 | Normal / No ARDS |
200 – 300 | Mild ARDS |
100 – 200 | Moderate ARDS |
< 100 | Severe ARDS |
The Horowitz index (P/F ratio) is PaO2 divided by FiO2 and is used to quantify hypoxemia, including staging ARDS in the Berlin definition; thresholds of 300, 200, and 100 mmHg correspond to mild, moderate, and severe ARDS, respectively, and SpO2/FiO2 is an acceptable surrogate when arterial gases are unavailable in many settings.
https://litfl.com/pao2-fio2-ratio/
ARDS severity is categorized by P/F with PEEP ≥5 cm H2O and acute onset with bilateral opacities not fully explained by cardiac failure; P/F 201–300 (mild), 101–200 (moderate), ≤100 (severe)
https://pmc.ncbi.nlm.nih.gov/articles/PMC8075801/
Because P/F depends on ventilator settings, a proposed P/FP metric (PaO2/(FiO2×PEEP)) reclassifies a substantial fraction of patients and may better align severity with support intensity, though it is not yet guideline standard
https://pmc.ncbi.nlm.nih.gov/articles/PMC8350287/
For a given shunt, P/F falls as FiO2 rises; estimating the “best” FiO2 when calculating P/F can reduce variability and improve comparability across patients and time
https://pmc.ncbi.nlm.nih.gov/articles/PMC9374145/
Particularly helpful for triage, resource‑limited settings, and continuous monitoring; accuracy declines at very high SpO2 values due to saturation curve flattening
https://pmc.ncbi.nlm.nih.gov/articles/PMC8664040/
Frequently Asked Questions
Features and Services FAQs
Discover the full range of features and services we offer and how to use them.
Ready to Transform Your Practice?
Join thousands of clinicians saving hours daily with AI-powered documentation.
14-day free trial • No setup fees
Ready to Transform Your Practice?
Join thousands of clinicians saving hours daily with AI-powered documentation.
14-day free trial • No setup fees
Ready to Transform Your Practice?
Join thousands of clinicians saving hours daily with AI-powered documentation.
14-day free trial • No setup fees
DocScrib
AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.
DocScrib
AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.
DocScrib
AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.